ACORN BIOVENTURES, L.P. - 25 Jun 2025 SCHEDULE 13G Report for Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
Candel Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
CADL
Shares outstanding
49.6M shares
Disclosed Ownership
2.58M shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
30 Jun 2025, 09:55:23 UTC
Date of event
25 Jun 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 1.08M 0 1.08M Anders Hove Manager of General Partner
ACORN BIOVENTURES 2, L.P. 3% 1.5M 0 1.5M Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 1.08M 0 1.08M Anders Hove Manager
Acorn Capital Advisors GP2, LLC 3% 1.5M 0 1.5M Anders Hove Manager
Anders Hove 5.2% 2.58M 0 2.58M Anders Hove Individually